2019³â ´ëÇÑ°¨¿°ÇÐȸ Á¦3ȸ °¨¿°°ü¸® ÃÖ½ÅÁö°ß : 2019-11-02±³À°ÀÏÀÚ : 2019-11-02
±³À°Àå¼Ò : °í·ÁÀÇ´ë À¯±¤»çȦ
±³À°ÁÖÁ¦ :
2019³â ´ëÇÑ°¨¿°ÇÐȸ Á¦3ȸ °¨¿°°ü¸® ÃÖ½ÅÁö°ßÁÖÃÖ±â°ü : ´ëÇÑ°¨¿°ÇÐȸ
´ã´çÀÚ : Á¶À¯Áø
¿¬¶ôó : 02-2055-1441
À̸ÞÀÏ :
ksinfect@ksid.or.kr ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú¿¹¹æÀÇÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø 100,000 / ºñȸ¿ø 120,000 ÇöÀåµî·Ï ȸ¿ø+ºñȸ¿ø 150,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-02 À¯±¤»çȦ 08:50~09:00 Introduction °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 09:00~09:50 Carbapenemase-producing Enterobacteriaceae, Emerging threat in healthcare-associated infections À̽¼ø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 09:50~10:40 Rapid diagnostics for antimicrobial-resistant pathogens ¹ÚÁ¤¼ö(¼¿ïÀÇ´ë)
Åä·Ð 11-02 À¯±¤»çȦ 10:40~11:00 Q & A on MDRO °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 11:00~11:50 Vaccine-preventable viral infections including measles and varicella °Áö¸¸(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 11:50~12:40 Clostridioides difficile infection in hospitalized patients ±èÁöÀº(ÇѾçÀÇ´ë)
Åä·Ð 11-02 À¯±¤»çȦ 12:40~13:00 Q & A on hospital outbreak °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)
½Ä»ç 11-02 À¯±¤»çȦ 13:00~14:00 Lunch break ()
±³À°½Ã°£ 11-02 À¯±¤»çȦ 14:00~14:50 Infection prevention and control practice in hematopoietic stem cells transplantation units À̵¿°Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 14:50~15:40 Infection prevention and control practice in emergency department Á¶¼±¿µ(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-02 À¯±¤»çȦ 15:40~16:00 Q & A on Infection prevention and control in special settings °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 16:00~16:50 Prevention and management of HAP & VAP À̹̼÷(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-02 À¯±¤»çȦ 16:50~17:40 Prevention and management of catheter-associated urinary tract infections À±¿µ°æ(°í·ÁÀÇ´ë)
Åä·Ð 11-02 À¯±¤»çȦ 17:40~18:00 Q & A on HAIs °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)